Gregory M. Luce

FDA Schedules Public Hearing on the Use of the Internet and Social Media in the Promotion of FDA-Regulated Products
John T. Bentivoglio, Jennifer L. Bragg, Jose A. Esteves, Stuart D. Levi, Gregory M. Luce, November 9, 2009
The United States Food and Drug Administration (FDA) has issued a notice of public hearing and request for comments to discuss issues related to the promotion of FDA-regulated products (e.g., prescription drugs, prescription biologics and medical devices) using the Internet and social media tools....

"The Expanding (and Evolving) Role of State Attorneys General in Drug and Device Regulation and Enforcement"
Gregory M. Luce, John T. Bentivoglio, Jennifer L. Bragg, John H. Beisner, October 26, 2009
The Food and Drug Administration (FDA) and its federal partners have long been the primary regulators of America's pharmaceutical and medical device industries. Within the last five years, however, the landscape has shifted. State attorneys general (AGs) have emerged as major investigators of the...

Pharmaceutical and Device Enforcement Update: Prosecutors Are Using New Theories of Liability in Criminal and Civil Matters
Gregory M. Luce, Mitchell S. Ettinger, John Bentivoglio, August 5, 2009
Federal and state agencies continue to target pharmaceutical and medical device manufacturers for what the agencies deem to be improper sales, marketing and other activities.